: MEDISTEP · Personal Care
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Growth · Profitability · Valuation · Strength · Conviction
Medistep Healthcare Ltd is engaged in the manufacturing of sanitary pads and energy powders. Additionally, the company trades and distributes a diverse portfolio of healthcare products, including pharmaceutical formulations, nutraceuticals, intimate care items, and surgical supplies.
The company operates through a hybrid model combining in-house manufacturing of hygiene and wellness products with the trading and distribution of third-party healthcare and pharmaceutical goods.
Growth is expected to be driven by the expansion of its product distribution network and the scaling of its manufacturing capabilities in the personal care and nutraceutical segments.
Unlock AI insights, financials, peers and live data on Medistep Health. and 5,000+ companies — free.
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Medistep Health.MEDISTEP | ₹28 Cr | — | — | — | 11.7% | — | — | -45.8% |
Gillette India Ltd.GILLETTE | ₹23,839 Cr | 35.68 | 23.88 | 38.3% | 31.1% | 67.8% | 83.2% | -27.5% |
Emami Ltd.EMAMILTD | ₹16,561 Cr | 22.12 | 15.61 | 2.8% | 27.0% | 26.7% | 30.3% | -33.9% |
Honasa Consumer Ltd.HONASA | ₹15,344 Cr | 61.60 | 39.78 | 21.1% | 15.0% | 19.2% | 23.6% | +60.7% |
Bajaj Consumer Care LimitedBAJAJCON | ₹6,236 Cr | 28.59 | 21.34 | 25.8% | 23.5% | 29.7% | 36.0% | +103.7% |
Anondita Medi.ANONDITA | ₹1,919 Cr | — | — | — | 35.0% | — | — | — |
As of Mar 2026
Medistep Health.
: MEDISTEP · Personal Care
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Growth · Profitability · Valuation · Strength · Conviction
Medistep Healthcare Ltd is engaged in the manufacturing of sanitary pads and energy powders. Additionally, the company trades and distributes a diverse portfolio of healthcare products, including pharmaceutical formulations, nutraceuticals, intimate care items, and surgical supplies.
The company operates through a hybrid model combining in-house manufacturing of hygiene and wellness products with the trading and distribution of third-party healthcare and pharmaceutical goods.
Growth is expected to be driven by the expansion of its product distribution network and the scaling of its manufacturing capabilities in the personal care and nutraceutical segments.
Unlock AI insights, financials, peers and live data on Medistep Health. and 5,000+ companies — free.
As of Mar 2026